• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗库溴铵 0.3 或 0.9mg/kg 用于 80 岁及以上患者时起效时间、作用持续时间和插管条件的比较:一项随机研究。

Rocuronium 0.3 or 0.9 mg/kg comparing onset time, duration of action, and intubating conditions in patients 80 years and older: A randomized study.

机构信息

Department of Anaesthesia, Centre of Head and Orthopedics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Department of Anaesthesia, Juliane Marie Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

出版信息

Acta Anaesthesiol Scand. 2022 Aug;66(7):811-817. doi: 10.1111/aas.14097. Epub 2022 Jun 27.

DOI:10.1111/aas.14097
PMID:35675032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9544287/
Abstract

BACKGROUND

Limited data exist about the optimal dose of rocuronium for intubation in elderly patients. We hypothesized that rocuronium 0.9 mg/kg would lead to a shorter onset time than 0.3 mg/kg in patients above 80 years.

METHODS

Thirty-four patients were randomized to either rocuronium 0.3 or 0.9 mg/kg. The primary outcome was onset time defined as time to train-of-four (TOF) count of 0. Other outcomes included duration of action (time to TOF ratio >0.9), proportion of excellent intubating conditions using the Fuchs-Buder scale and tracheal intubating conditions using the Intubating Difficulty Scale (IDS).

RESULTS

Rocuronium 0.9 mg/kg resulted in shorter onset time compared to rocuronium 0.3 mg/kg; 108 s (SD 40) vs. 228 s (SD 140) (difference: 119 s [95% CI: 41-196], p = .005), respectively. However, in 66% of the patients receiving rocuronium 0.3 mg/kg a TOF count of 0 was not obtained. Duration of action was longer after rocuronium 0.9 mg/kg: 118 min (SD 43) vs. 46 min (SD 13) (difference: 72 min [95% CI: 49-95] p < .0001), and a greater proportion of excellent intubating conditions (Fuchs-Buder) was obtained; 11/16 (69%) vs 4/18 (22%) (p = .006). No difference was found regarding IDS score.

CONCLUSION

Rocuronium 0.9 mg/kg resulted in a shorter onset time compared to rocuronium 0.3 mg/kg in patients above 80 years of age. In 66% of the patients receiving rocuronium 0.3 mg/kg a TOF count of 0 was not obtained.

摘要

背景

关于老年患者插管时罗库溴铵的最佳剂量,数据有限。我们假设罗库溴铵 0.9mg/kg 会比 0.3mg/kg 起效更快。

方法

34 名患者随机分为罗库溴铵 0.3 或 0.9mg/kg 组。主要结局是起效时间,定义为肌颤搐计数(TOF)达到 0 的时间。其他结局包括作用持续时间(TOF 比值>0.9 的时间)、Fuchs-Buder 插管条件评分和 Intubating Difficulty Scale(IDS)的气管插管条件评分。

结果

与罗库溴铵 0.3mg/kg 相比,罗库溴铵 0.9mg/kg 起效更快;108s(SD 40)vs. 228s(SD 140)(差异:119s [95% CI:41-196],p=0.005)。然而,66%的患者接受罗库溴铵 0.3mg/kg 后未能达到 TOF 计数为 0。罗库溴铵 0.9mg/kg 后作用持续时间更长:118min(SD 43)vs. 46min(SD 13)(差异:72min [95% CI:49-95],p<0.0001),且获得更好的插管条件(Fuchs-Buder)的比例更高;11/16(69%)vs 4/18(22%)(p=0.006)。IDS 评分无差异。

结论

与罗库溴铵 0.3mg/kg 相比,80 岁以上患者接受罗库溴铵 0.9mg/kg 起效更快。66%的患者接受罗库溴铵 0.3mg/kg 后未能达到 TOF 计数为 0。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b76/9544287/48e91b8fad01/AAS-66-811-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b76/9544287/48e91b8fad01/AAS-66-811-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b76/9544287/48e91b8fad01/AAS-66-811-g001.jpg

相似文献

1
Rocuronium 0.3 or 0.9 mg/kg comparing onset time, duration of action, and intubating conditions in patients 80 years and older: A randomized study.罗库溴铵 0.3 或 0.9mg/kg 用于 80 岁及以上患者时起效时间、作用持续时间和插管条件的比较:一项随机研究。
Acta Anaesthesiol Scand. 2022 Aug;66(7):811-817. doi: 10.1111/aas.14097. Epub 2022 Jun 27.
2
Tracheal intubating conditions in elderly patients when train-of-four count is zero after rocuronium 0.6 or 0.9 mg/kg. A secondary analysis.罗库溴铵 0.6 或 0.9mg/kg 后肌松监测四个成串刺激计数为零时老年患者的气管插管条件。一项二次分析。
J Clin Monit Comput. 2023 Aug;37(4):1045-1050. doi: 10.1007/s10877-023-01012-6. Epub 2023 Apr 29.
3
Onset time, duration of action, and intubating conditions after mivacurium in elderly and younger patients.老年和年轻患者使用米库氯铵后的起效时间、作用持续时间和插管条件。
Acta Anaesthesiol Scand. 2024 Aug;68(7):898-905. doi: 10.1111/aas.14440. Epub 2024 May 19.
4
A blinded randomized study comparing intubating conditions after either rocuronium 0.6 mg·kg or remifentanil 2 µg·kg in elderly patients.一项比较罗库溴铵 0.6mg·kg 或瑞芬太尼 2μg·kg 用于老年患者插管条件的盲法随机研究。
Acta Anaesthesiol Scand. 2021 Nov;65(10):1367-1373. doi: 10.1111/aas.13957. Epub 2021 Sep 5.
5
Comparison of onset time, duration of action, and intubating conditions after cisatracurium 0.15 mg/kg in young and elderly patients.0.15mg/kg 顺式阿曲库铵在年轻和老年患者中起效时间、作用持续时间和插管条件的比较。
BMC Anesthesiol. 2022 Nov 7;22(1):339. doi: 10.1186/s12871-022-01881-5.
6
[Intubation conditions and the development of neuromuscular blockade with rocuronium in endoscopic ORL surgery].[内镜耳鼻喉科手术中罗库溴铵的插管条件及神经肌肉阻滞的发展]
Anaesthesist. 1997 Jan;46(1):14-20. doi: 10.1007/s001010050365.
7
High-dose rocuronium-induced paralysis of the adductor pollicis muscle facilitates detection of the timing for tracheal intubation in elderly patients: a randomized double-blind study.高剂量罗库溴铵诱导拇内收肌麻痹有助于老年患者气管插管时机的检测:一项随机双盲研究。
J Anesth. 2020 Dec;34(6):876-880. doi: 10.1007/s00540-020-02831-6. Epub 2020 Jul 23.
8
Comparison of intubating conditions after rocuronium or vecuronium when the timing of intubation is judged by clinical criteria.根据临床标准判断插管时机时,罗库溴铵与维库溴铵用于插管条件的比较。
Br J Anaesth. 1998 Feb;80(2):235-7. doi: 10.1093/bja/80.2.235.
9
[Optimum intubating dose of rocuronium for short duration surgery in adult patients].
Masui. 2010 Feb;59(2):160-3.
10
Ketamine, but not priming, improves intubating conditions during a propofol-rocuronium induction.氯胺酮而非预注能改善依托咪酯-罗库溴铵诱导时的插管条件。
Can J Anaesth. 2010 Feb;57(2):113-9. doi: 10.1007/s12630-009-9217-4. Epub 2009 Nov 12.

引用本文的文献

1
The electromyographic single twitch stimulation for monitoring the effect of rocuronium on vocal cord opening - a randomised controlled trial.用于监测罗库溴铵对声带开放影响的肌电图单次抽搐刺激——一项随机对照试验
BMC Anesthesiol. 2025 Jul 3;25(1):333. doi: 10.1186/s12871-025-03201-z.
2
Use and Outcomes of Sugammadex for Neurological Examination after Neuromuscular Blockade in the Emergency Department.急诊科神经肌肉阻滞后使用舒更葡糖钠进行神经学检查的情况及结果
West J Emerg Med. 2025 Mar;26(2):347-352. doi: 10.5811/westjem.29328.
3
Intubating conditions during rapid sequence induction with either rocuronium or suxamethonium in elderly patients. A randomised study.

本文引用的文献

1
A blinded randomized study comparing intubating conditions after either rocuronium 0.6 mg·kg or remifentanil 2 µg·kg in elderly patients.一项比较罗库溴铵 0.6mg·kg 或瑞芬太尼 2μg·kg 用于老年患者插管条件的盲法随机研究。
Acta Anaesthesiol Scand. 2021 Nov;65(10):1367-1373. doi: 10.1111/aas.13957. Epub 2021 Sep 5.
2
Onset time and duration of action of rocuronium 0.6 mg/kg in patients above 80 years of age: A comparison with young adults.80 岁以上患者罗库溴铵 0.6mg/kg 的起效时间和作用持续时间:与年轻人的比较。
Acta Anaesthesiol Scand. 2020 Sep;64(8):1082-1088. doi: 10.1111/aas.13645. Epub 2020 Jun 18.
3
老年患者在使用罗库溴铵或琥珀酰胆碱进行快速顺序诱导时的插管条件。一项随机研究。
Acta Anaesthesiol Scand. 2025 Mar;69(3):e14589. doi: 10.1111/aas.14589.
4
Tracheal intubating conditions in elderly patients when train-of-four count is zero after rocuronium 0.6 or 0.9 mg/kg. A secondary analysis.罗库溴铵 0.6 或 0.9mg/kg 后肌松监测四个成串刺激计数为零时老年患者的气管插管条件。一项二次分析。
J Clin Monit Comput. 2023 Aug;37(4):1045-1050. doi: 10.1007/s10877-023-01012-6. Epub 2023 Apr 29.
Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study.
肌松药使用后全身麻醉后肺部并发症(POPULAR):一项多中心、前瞻性观察研究。
Lancet Respir Med. 2019 Feb;7(2):129-140. doi: 10.1016/S2213-2600(18)30294-7. Epub 2018 Sep 14.
4
Effects of avoidance or use of neuromuscular blocking agents on outcomes in tracheal intubation: a Cochrane systematic review.避免或使用神经肌肉阻滞剂对气管插管结果的影响:一项 Cochrane 系统评价。
Br J Anaesth. 2018 Jun;120(6):1381-1393. doi: 10.1016/j.bja.2017.11.106. Epub 2018 Apr 4.
5
Evaluation of three unchannelled videolaryngoscopes and the Macintosh laryngoscope in patients with a simulated difficult airway: a randomised, controlled trial.评估三种无管视频喉镜和 Macintosh 喉镜在模拟困难气道患者中的应用:一项随机对照试验。
Anaesthesia. 2017 Mar;72(3):370-378. doi: 10.1111/anae.13714. Epub 2016 Nov 24.
6
Comparison of rocuronium at two different doses and succinylcholine for endotracheal intubation in adult patients for elective surgeries.在择期手术成年患者中,比较两种不同剂量的罗库溴铵与琥珀酰胆碱用于气管插管的效果。
Saudi J Anaesth. 2016 Oct-Dec;10(4):379-383. doi: 10.4103/1658-354X.177330.
7
Ease of intubation: A randomized, double-blind study to compare two doses of rocuronium bromide for endotracheal intubation.插管的难易程度:一项比较两种剂量的罗库溴铵用于气管插管的随机双盲研究。
Anesth Essays Res. 2016 Sep-Dec;10(3):512-515. doi: 10.4103/0259-1162.179308.
8
Residual Neuromuscular Block in the Elderly: Incidence and Clinical Implications.老年人的残余神经肌肉阻滞:发生率和临床意义。
Anesthesiology. 2015 Dec;123(6):1322-36. doi: 10.1097/ALN.0000000000000865.
9
Influence of age and gender on the pharmacodynamic parameters of rocuronium during total intravenous anesthesia.年龄和性别对全凭静脉麻醉期间罗库溴铵药效学参数的影响。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Dec;155(4):347-53. doi: 10.55.07/bp.2011.050.
10
Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block.残余神经肌肉阻滞:未吸取的教训。第一部分:定义、发生率和残余神经肌肉阻滞的不良生理效应。
Anesth Analg. 2010 Jul;111(1):120-8. doi: 10.1213/ANE.0b013e3181da832d. Epub 2010 May 4.